Linda J. Rennick

Recurrent deletions in the SARS-CoV-2 spike glycoprotein drive antibody escape

Kevin R. McCarthy, Linda J. Rennick, Sham Nambulli et al. · Science · 2021 · 584 citations · Full text

Viral Evolution, Deletion Variants, Pathogenesis +15

Early Target Cells of Measles Virus after Aerosol Infection of Non-Human Primates

Ken Lemon, Rory D. de Vries, Annelies W. Mesman et al. · PLoS Pathogens · 2011 · 212 citations · Full text

Inhalable Nanobody (PiN-21) prevents and treats SARS-CoV-2 infections in Syrian hamsters at ultra-low doses

Sham Nambulli, Yufei Xiang, Natasha L. Tilston‐Lunel et al. · Science Advances · 2021 · 161 citations · Full text

SARS-CoV-2 growth, furin-cleavage-site adaptation and neutralization using serum from acutely infected hospitalized COVID-19 patients

William B. Klimstra, Natasha L. Tilston‐Lunel, Sham Nambulli et al. · Journal of General Virology · 2020 · 153 citations · Full text

Intractable Coronavirus Disease 2019 (COVID-19) and Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Replication in a Chimeric Antigen Receptor-Modified T-Cell Therapy Recipient: A Case Study

Matthew K. Hensley, William Bain, Jana L. Jacobs et al. · Clinical Infectious Diseases · 2021 · 138 citations · Full text

Viral Diagnostics, Intractable Rnaemia, Immunodeficiencies +16